Eprosartan effects on intravascular platelet activity in patients with arterial hypertension and metabolic syndrome
Aim: To study therapeutic effects of eprosartan on intravascular platelet activity in patients with arterial hypertension (AH) and metabolic syndrome (MS). Material and methods: In total, 32 participants received eprosartan (600 mg/d) for 4 months. Dynamics of lipid peroxidation in plasma and platel...
Saved in:
| Main Authors: | I. N. Medvedev, T. A. Kumova |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«FIRMA «SILICEA» LLC
2008-02-01
|
| Series: | Российский кардиологический журнал |
| Subjects: | |
| Online Access: | https://russjcardiol.elpub.ru/jour/article/view/1525 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparison of platelet hemostasis effects for angiotensin receptor blockers in patients with arterial hypertension and metabolic syndrome
by: I. N. Medvedev, et al.
Published: (2007-08-01) -
Valsartan effects on platelet activity in patients with arterial hypertension and metabolic syndrom
by: I. N. Medvedev, et al.
Published: (2007-06-01) -
Intravascular platelet activity correction by fosinopril in arterial hypertension patients with metabolic syndrome
by: I. N. Medvedev, et al.
Published: (2006-10-01) -
THE EFFECTIVENESS OF CARVEDILOL AND EPROSARTAN IN PATIENTS WITH METABOLIC SYNDROME AND CHRONIC HEART FAILURE
by: R. L. Dashnamirov
Published: (2014-04-01) -
Clinical effectiveness of eprosartan and hydroxyzine in patients with mild to moderate arterial hypertension and coexisting anxiety
by: G. V. Pogosova, et al.
Published: (2009-02-01)